MedPath

Study of Intensive Care Units in India

Completed
Conditions
Critical Illness
Registration Number
NCT01384929
Lead Sponsor
Indian Society of Critical Care Medicine
Brief Summary

There is scant data on the casemix and practices in Indian intensive care units (ICUs). Most of the available data comes from single centre studies. There is a dire need to have data from Indian ICUs to reflect the vast spectrum of critical care illness, services and practices. INDICAPS planned to collect data of all patients in the ICU on one particular day, and four such days spread throughout a one-year period were selected: the second Wednesday of July and October this year, i.e. July 14 and October 13, 2010 and the second Wednesday of January and April next year, i.e. January 12 and April 13, 2011. As many ICUs all over the country as possible were asked to participate. The investigators aimed to gather information about ICUs, patients in ICUs, the types and severity of illness, monitoring and therapeutic modalities used, types of infections,mortality rates, etc.

Detailed Description

The following information will be analysed:

Case-mix, severity of illness, prevalence of infection, hemodynamic monitoring and therapy, mechanical ventilation practices, nutrition and outcome

* Seasonal and regional variations in the above

* Epidemiology and variations in antibiotic use

* Patterns of microorganisms and outcome

* Prevalence and outcome of specific tropical febrile illnesses, including malaria, dengue fever, leptospirosis, scrub typhus

* Prevalence and outcome of toxins and poisonings

* Relation of ICU and hospital organizational issues to prevalence of infection and outcome

* Organisation of intensive care services

* End of life - Ethical decisions

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
4236
Inclusion Criteria
  • All patients present in the ICU July 14, 2010, October 13, 2010, January 12, 2011 and April 13, 2011
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
All cause mortality30-days
Secondary Outcome Measures
NameTimeMethod
ICU Length of stay30 days

Stay in ICU till 30 days

Hospital length of stay30 days

Stay in hospital till 30 days

Hospital survival30 days

Survival at hospital discharge or at 30 days

Trial Locations

Locations (1)

Tata Memorial Hospital

🇮🇳

Mumbai, Maharashtra, India

© Copyright 2025. All Rights Reserved by MedPath